Recent advances in the biology and drug targeting of malaria parasite aminoacyl-tRNA synthetases

10Citations
Citations of this article
33Readers
Mendeley users who have this article in their library.

Abstract

Escalating drug resistance in malaria parasites and lack of vaccine entails the discovery of novel drug targets and inhibitor molecules. The multi-component protein translation machinery is a rich source of such drug targets. Malaria parasites contain three translational compartments: the cytoplasm, apicoplast and mitochondrion, of which the latter two are of the prokaryotic type. Recent explorations by many groups into the malaria parasite protein translation enzymes, aminoacyl-tRNA synthetases (aaRSs), have yielded many promising inhibitors. The understanding of the biology of this unique set of 36 enzymes has become much clearer in recent times. Current review discusses the advances made in understanding of crucial aaRSs from Plasmodium and also the specific inhibitors found against malaria aaRSs.

Cite

CITATION STYLE

APA

Khan, S. (2016, April 12). Recent advances in the biology and drug targeting of malaria parasite aminoacyl-tRNA synthetases. Malaria Journal. BioMed Central Ltd. https://doi.org/10.1186/s12936-016-1247-0

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free